Skip to main content
Clinical Trials/IRCT20200218046533N1
IRCT20200218046533N1
Recruiting
Phase 2

The Evaluation of the Efficacy of Calcitriol Compared to Calcitriol plus Cinacalcet in the Treatment of Severe Secondary Hyperparathyroidism in Hemodialysis Patients Referred to Dialysis Centers in Gorgan

Gorgan University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Gorgan University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gorgan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years and more;
  • Dialysis for at least 3 months;
  • iPTH levels above 800 pg/dL (severe secondary hyperparathyroidism);
  • Do not take medications that have drug interactions such as flecainide, thioridazine, tricyclic antidepressants due to the effect of Cinacalcet on the P\-450 cytochrome;
  • No hypersensitivity reaction to the drugs used in the study;
  • No liver disease;
  • Calcium levels \> 8\.4 mg/dL.

Exclusion Criteria

  • Any evidence of cancer in different parts of the body;
  • Side effects of the medications used during the study period;
  • Diseases causing hypercalcemia;
  • History of parathyroidctomy;
  • Presence of parathyroid adenoma (to be confirmed by parathyroid scan);
  • Pregnant mothers or lactating women or females of childbearing age who do not currently use contraception.

Outcomes

Primary Outcomes

Not specified

Similar Trials